Peptide YY in gastrointestinal disorders

Peptides

Volumn 23, Issue 2, 2002, Pages 397-402

  El Salhy, Magdy ^a   Suhr, Ole ^a   Danielsson, Åke ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; Gastrointestinal disorders; Inflammatory bowel diseases; Motility; PYY; Secretion

Indexed keywords

PEPTIDE YY;

ANOREXIA NERVOSA; ARTICLE; BULIMIA; CELIAC DISEASE; CELL COUNT; COLORECTAL CARCINOMA; CONSTIPATION; ENTERITIS; GASTRECTOMY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE ADAPTATION; INTESTINE CELL; INTESTINE RESECTION; INTESTINE TRANSIT TIME; NEUROMUSCULAR DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ANOREXIA; CELIAC DISEASE; COLORECTAL NEOPLASMS; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; NEUROMUSCULAR DISEASES; PEPTIDE YY;

EID: 0036161888     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00617-9     Document Type: Article

References (64)

1. Peptide YY abnormalities in gastrointestinal diseases
2. Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog
3. Gastrointestinal regulatory peptides in systemic sclerosis
4. Colonic endocrine cells in patients with familial amyloidotic polyneuropathy
5. Familial amyloidosis with polyneuropathy: A clinical study based on patients living in northern Sweden
6. Human gut hormone profiles in patients with short bowel syndrom
7. Gut hormones, growth and malignancy
8. Colonic mass movement in idiopathic chronic constipation
9. Prolonged (24-hours) manometeric recording of rectal contractile activity in patients with slow transit constipation
10. Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation
11. Colonic scintigraphy and manometry in constipation, diarrhoea and inflammatory bowel disease
12. Cerebrospinal fluid peptide YY immunoreactivity in eating disorders
13. Growth regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on non-transformed intestinal epithelial cell line IEC-6, and colon cancer cell line HT 29
14. 34] Npy and PP in a human colonic epithelial cell line
15. Invited review: The nature and implication of intestinal endocrine cell changes in coeliac disease
16. Neuroendocrine peptide contents in the gastrointestinal tract of an animal model for human diabetes type 2
17. Neuroendocrine peptides in stomach and colon of an animal model for human diabetes type I
18. Gastrointestinal transit in non-obese diabetic mouse: An animal model of human diabetes typ1
19. Gastrointestinal transit in an animal model of human diabetes typ 2: Relationship to gut neuropeptide contents
20. Colonic endocrine cells in inflammatory bowel disease
21. Low levels of colonic somatostatin and galanin in patients with colon carcinoma
22. Colonic neuroendocrine peptide levels in patients with chronic idiopathic slow transit constipation
23. Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation
24. Colonic endocrine cells in patients with carcinoma of the rectum with special regard to preoperative irradiation
25. Colonic endocrine cells in patients with carcinoma of the colon
26. Abnormal gastrointestinal endocrine cells in patients with diabetes type 1: Relationship to gastric emptying
27. Enocrine cells in rectal biopsy specimens from patients with familial amyloidos and polyneuropathy
28. Colonic neuroendocrine peptides in rats with chemically-induced colon carcinoma
29. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects
30. Disorders of gastrointestinal motility associated with diabetes mellitus
31. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients
32. Altered cerebrospinal fluid neuropeptide Y and peptide immunoreactivity in anorexia and bulimia nervosa
33. Nutrition and physical activity in chronic constipation
34. Diabetic gastropathy. Gastric neuromuscular dysfunction in diabetes mellitus. A review of symptoms, pathophysiology and treatment
35. Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel disease
36. Peptide YY concentrations in normal ileum, and colon, and in idiopathic inflammatory bowel disease
37. Peptide YY: A potential proabsorptive hormone for the treatment of malabsorption disorders
38. A novel synthetic analog of peptide YY, BIM-43004, given intraluminally, is proabsorptive
39. Epidiemiology of gastrointestinal complications of diabetes mellitus
40. Idiopathic slow-transit constipation
41. The pancreatic polypeptide family
42. Plasma cholecystokinin, plasma peptide YY and gallbladder motility in patients with slow transit constipation: Effect of intestinal stimulation
43. Enteroglucagon and peptide YY response after construction of pelvic reservoir in humans
44. The enterochromaffin cells in the mouse gastrointestinal tract after streptozotocin treatment
45. Severe chronic constipation of young women: "Idiopathic slow transit constipation"
46. Neuroendocrine changes in interleukin-2 (IL-2) gene deleted mice with colonic inflammation
47. Intestinal endocrine cells in myotonic dystrophy: An immunohistochemical and computed image analytical study
48. Increased prevalence of gastrointestinal symptoms in long-term type 1 diabetes mellitus
49. Colonic endocrine cells in rats with chemically induced colon carcinoma
50. Inceased plasma level of peptide YY in coeliac disease
51. Neuropeptides in idiopathic chronic slow transit constipation
52. The "ileal brake" after ileal pouch-anal anastomosis
53. Large intestinal endocrine cells in non-obese diabetic NOD-mice
54. Gastrointestinal endocrine cells in an animal model for human type 2 diabetes
55. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients
56. Does diabetic state affect co-localisation of peptide YY (PYY) and enteroglucagon in colonic endocrine cells
57. Familial amyloidosis with polyneuropathy. A long term follow-up of 21 patients with reference to gastrointestinal symptoms
58. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of patients with familial amyloidosis with polyneuropathy
59. Peptide YY abnormalities in patients with ulcerative colitis
60. Selective inhibition of neuropeptide YY, receptors by BIBP3226 in rat and human epithelial preparetions
61. Circulating gastrointestinal hormone abnormalities in patients with severe idiopathic constipation
62. Gastrointestinal hormone in dumping syndrom and reflux esophigitis after gastric surgery